Position in BNTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$554,205
+$71,409 QoQ
Shares Held
5,956
+9.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#147
of 282 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $498,673,295 across 59 Biotechnology names. BNTX ranks #51 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
135,783 | $84,666,131 | |
| 2 | INCY |
Incyte Corp
|
634,862 | $71,967,956 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
931,864 | $53,321,258 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
102,928 | $51,127,425 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
298,440 | $22,227,811 | |
| 6 | TBPH |
Theravance Biopharma, Inc.
|
985,848 | $16,759,416 | |
| 7 | RPRX |
Royalty Pharma plc
|
270,457 | $15,164,523 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
43,988 | $13,241,707 |
All Filings in BNTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $554,205 | 5,956 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $482,796 | 5,432 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $426,972 | 4,485 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $423,079 | 4,290 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $439,188 | 4,125 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $341,748 | 3,753 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $444,746 | 3,903 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $2,764,134 | 23,273 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,371,423 | 17,066 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,775,710 | 30,089 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,308,581 | 21,874 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $557,430 | 5,131 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $296,915 | 2,751 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $289,002 | 2,320 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $1,329,446 | 8,850 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,100,485 | 8,159 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $708,672 | 4,753 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $264,197 | 1,549 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $824,702 | 3,199 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $289,915 | 1,062 | Shares | Sole | 2021-11-08 | |
| 2020-12-31 | $203,881 | 2,501 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||